Alex Nisthal, PhD

Group Leader, Protein Engineering at Xencor

Dr. Nisthal is a Group Leader in the Protein Engineering department at Xencor. Since joining Xencor in 2016, Dr. Nisthal has led the early development of several drug programs for oncology, including 2+1 CD3 bispecifics and engineered cytokines. He has made contributions to diverse efforts within Xencor, including in silico target discovery, antibody discovery library design, and modern data management. Prior to Xencor Dr. Nisthal worked as a staff scientist at Caltech, where he contributed to the protein engineering of broadly neutralizing antibodies against influenza as well as enzymes for industrial biotech applications. He holds a Ph.D. in Biochemistry and Molecular Biophysics from Caltech, and a B.S. in Biotechnology from CSU Pomona.